Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou; Chien-Chin Lin; Ming-Chung Kuo; Shyuann-Yuh Lin; Jyh-Pyng Gau; Ming-Chung Wang; Ming-Chih Chang; Tsung-Chih Chen; Su-Peng Yeh; Yeu-Chin Chen; Cih-En Huang; Chieh-Wen Chen; Yee-Ming Lee; Fan-Chen Ku; Lee-Yung Shih

doi:10.1182/blood-2019-129645

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou, Chien-Chin Lin, Ming-Chung Kuo, Shyuann-Yuh Lin, Jyh-Pyng Gau, Ming-Chung Wang, Ming-Chih Chang, Tsung-Chih Chen, Su-Peng Yeh, Yeu-Chin Chen, Cih-En Huang, Chieh-Wen Chen, Yee-Ming Lee, Fan-Chen Ku, Lee-Yung Shih

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/blood-2019-129645
State	Published - 2019

Access to Document

10.1182/blood-2019-129645

Cite this

Hou, H.-A., Lin, C.-C., Kuo, M.-C., Lin, S.-Y., Gau, J.-P., Wang, M.-C., Chang, M.-C., Chen, T.-C., Yeh, S.-P., Chen, Y.-C., Huang, C.-E., Chen, C.-W., Lee, Y.-M., Ku, F.-C., & Shih, L.-Y. (2019). Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan. Blood, 134. https://doi.org/10.1182/blood-2019-129645

@article{55d040b92d824b288fd406df2f219c6c,

title = "Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan",

author = "Hsin-An Hou and Chien-Chin Lin and Ming-Chung Kuo and Shyuann-Yuh Lin and Jyh-Pyng Gau and Ming-Chung Wang and Ming-Chih Chang and Tsung-Chih Chen and Su-Peng Yeh and Yeu-Chin Chen and Cih-En Huang and Chieh-Wen Chen and Yee-Ming Lee and Fan-Chen Ku and Lee-Yung Shih",

year = "2019",

doi = "10.1182/blood-2019-129645",

language = "American English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

}

Hou, H-A, Lin, C-C, Kuo, M-C, Lin, S-Y, Gau, J-P, Wang, M-C, Chang, M-C, Chen, T-C, Yeh, S-P, Chen, Y-C, Huang, C-E, Chen, C-W, Lee, Y-M, Ku, F-C & Shih, L-Y 2019, 'Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan', Blood, vol. 134. https://doi.org/10.1182/blood-2019-129645

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan. / Hou, Hsin-An; Lin, Chien-Chin; Kuo, Ming-Chung et al.
In: Blood, Vol. 134, 2019.

Research output: Contribution to journal › Journal Article › peer-review

TY - JOUR

T1 - Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

AU - Hou, Hsin-An

AU - Lin, Chien-Chin

AU - Kuo, Ming-Chung

AU - Lin, Shyuann-Yuh

AU - Gau, Jyh-Pyng

AU - Wang, Ming-Chung

AU - Chang, Ming-Chih

AU - Chen, Tsung-Chih

AU - Yeh, Su-Peng

AU - Chen, Yeu-Chin

AU - Huang, Cih-En

AU - Chen, Chieh-Wen

AU - Lee, Yee-Ming

AU - Ku, Fan-Chen

AU - Shih, Lee-Yung

PY - 2019

Y1 - 2019

U2 - 10.1182/blood-2019-129645

DO - 10.1182/blood-2019-129645

M3 - Journal Article

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

ER -